Trifecta Capital Advisors
RMD icon

Trifecta Capital Advisors’s ResMed RMD Stock Holding History

Trifecta Capital Advisors’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-1
Closed -$195 – 451
2026
Q2 		$195 Buy
+1
New +$207 ﹤0.01% 465
2025
Q4 		– Sell
-7
Closed -$1.92K – 412
2025
Q3 		$1.92K Hold
7
– – ﹤0.01% 340
2025
Q2 		$1.81K Hold
7
– – ﹤0.01% 350
2025
Q1 		$1.57K Hold
7
– – ﹤0.01% 333
2024
Q4 		$1.6K Hold
7
– – ﹤0.01% 328
2024
Q3 		$1.71K Hold
7
– – ﹤0.01% 329
2024
Q2 		$1.34K Hold
7
– – ﹤0.01% 353
2024
Q1 		$1.39K Hold
7
– – ﹤0.01% 344
2023
Q4 		$1.2K Buy
+7
New +$1.08K ﹤0.01% 381

Other funds holding RMD

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Trifecta Capital Advisors's RMD Position: Q3 2026 in Review

Trifecta Capital Advisors sold out of ResMed (RMD) in Q3 2026, closing a stake of 1 share — an estimated $195 sold.

Trifecta Capital Advisors first reported a position in RMD in Q4 2023 and held it in 9 quarters. The position peaked at $1.92K in Q3 2025. 442 funds tracked by Wall St. Rank hold RMD as of Q3 2026.

  • Trifecta Capital Advisors reported no remaining ResMed position as of Q3 2026 after selling out during the quarter.
  • Trifecta Capital Advisors sold 1 ResMed share in Q3 2026, an estimated $195.
  • Trifecta Capital Advisors first reported a position in ResMed in Q4 2023 and held it in 9 quarters.
  • Trifecta Capital Advisors's ResMed position peaked at $1.92K in Q3 2025.
  • 442 funds tracked by Wall St. Rank held ResMed as of Q3 2026.

Based on Trifecta Capital Advisors's 13F filing for Q3 2026, filed 21 Oct 2026.